| Officer | In this role | Source |
|---|---|---|
|
David Elsley
Also a director
Director, President and Chief Executive Officer
|
Not stated | |
|
Chris Waddick
Also a director
Director, Chief Financial Officer and Corporate Secretary
|
Not stated | |
|
Bernard Lim
Chief Operating Officer
|
Since 2020
6 years
|
|
|
Andrew Hamer
Chief Medical Officer and Head of Research and Development
|
Since 2021
5 years
|
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Related-party transactions come from the company’s proxy statement. Cardiol Therapeutics Inc. has not filed one with the SEC.
Loading...